Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:pharmacokinetic study'
(id=7256234 ; fe=en:pharmacokinetic study ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=3192 creation date=2017-06-26 touchdate=2025-07-24 23:42:51.000)
≈ 71 relations sortantes

  1. en:pharmacokinetic study -- r_associated #0: 35 / 1 -> étude pharmacocinétique
    n1=en:pharmacokinetic study | n2=étude pharmacocinétique | rel=r_associated | relid=0 | w=35
  2. en:pharmacokinetic study -- r_associated #0: 30 / 0.857 -> en:anti-d titration
    n1=en:pharmacokinetic study | n2=en:anti-d titration | rel=r_associated | relid=0 | w=30
  3. en:pharmacokinetic study -- r_associated #0: 29 / 0.829 -> en:phenolsulfonphthalein measurement
    n1=en:pharmacokinetic study | n2=en:phenolsulfonphthalein measurement | rel=r_associated | relid=0 | w=29
  4. en:pharmacokinetic study -- r_associated #0: 28 / 0.8 -> en:dimethadione measurement
    n1=en:pharmacokinetic study | n2=en:dimethadione measurement | rel=r_associated | relid=0 | w=28
  5. en:pharmacokinetic study -- r_associated #0: 26 / 0.743 -> en:clinical evaluation
    n1=en:pharmacokinetic study | n2=en:clinical evaluation | rel=r_associated | relid=0 | w=26
  6. en:pharmacokinetic study -- r_associated #0: 25 / 0.714 -> en:laboratory test order cancelation
    n1=en:pharmacokinetic study | n2=en:laboratory test order cancelation | rel=r_associated | relid=0 | w=25
  7. en:pharmacokinetic study -- r_associated #0: 23 / 0.657 -> en:evaluation of acid-base balance
    n1=en:pharmacokinetic study | n2=en:evaluation of acid-base balance | rel=r_associated | relid=0 | w=23
  8. en:pharmacokinetic study -- r_associated #0: 22 / 0.629 -> en:nuclear magnetic resonance measurement
    n1=en:pharmacokinetic study | n2=en:nuclear magnetic resonance measurement | rel=r_associated | relid=0 | w=22
  9. en:pharmacokinetic study -- r_associated #0: 21 / 0.6 -> en:mephenytoin measurement
    n1=en:pharmacokinetic study | n2=en:mephenytoin measurement | rel=r_associated | relid=0 | w=21
  10. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> centrifugation
    n1=en:pharmacokinetic study | n2=centrifugation | rel=r_associated | relid=0 | w=20
  11. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> constance de vitesse d'élimination
    n1=en:pharmacokinetic study | n2=constance de vitesse d'élimination | rel=r_associated | relid=0 | w=20
  12. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> dépistage de sang occulte dans les selles
    n1=en:pharmacokinetic study | n2=dépistage de sang occulte dans les selles | rel=r_associated | relid=0 | w=20
  13. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> dosage de l'acébutolol
    n1=en:pharmacokinetic study | n2=dosage de l'acébutolol | rel=r_associated | relid=0 | w=20
  14. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> dosage du thiopental
    n1=en:pharmacokinetic study | n2=dosage du thiopental | rel=r_associated | relid=0 | w=20
  15. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> dose
    n1=en:pharmacokinetic study | n2=dose | rel=r_associated | relid=0 | w=20
  16. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> effet indésirable d'un médicament
    n1=en:pharmacokinetic study | n2=effet indésirable d'un médicament | rel=r_associated | relid=0 | w=20
  17. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> électrophorèse
    n1=en:pharmacokinetic study | n2=électrophorèse | rel=r_associated | relid=0 | w=20
  18. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> Électrophorèse
    n1=en:pharmacokinetic study | n2=Électrophorèse | rel=r_associated | relid=0 | w=20
  19. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> electrophoresis
    n1=en:pharmacokinetic study | n2=electrophoresis | rel=r_associated | relid=0 | w=20
  20. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> électrophorétique
    n1=en:pharmacokinetic study | n2=électrophorétique | rel=r_associated | relid=0 | w=20
  21. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:acebutolol measurement
    n1=en:pharmacokinetic study | n2=en:acebutolol measurement | rel=r_associated | relid=0 | w=20
  22. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:acepromazine measurement
    n1=en:pharmacokinetic study | n2=en:acepromazine measurement | rel=r_associated | relid=0 | w=20
  23. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:acetaminophen assay
    n1=en:pharmacokinetic study | n2=en:acetaminophen assay | rel=r_associated | relid=0 | w=20
  24. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:activation test
    n1=en:pharmacokinetic study | n2=en:activation test | rel=r_associated | relid=0 | w=20
  25. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:adverse reaction to drug
    n1=en:pharmacokinetic study | n2=en:adverse reaction to drug | rel=r_associated | relid=0 | w=20
  26. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:area under curve
    n1=en:pharmacokinetic study | n2=en:area under curve | rel=r_associated | relid=0 | w=20
  27. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:bioassay
    n1=en:pharmacokinetic study | n2=en:bioassay | rel=r_associated | relid=0 | w=20
  28. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:bioavailability study
    n1=en:pharmacokinetic study | n2=en:bioavailability study | rel=r_associated | relid=0 | w=20
  29. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:breath test
    n1=en:pharmacokinetic study | n2=en:breath test | rel=r_associated | relid=0 | w=20
  30. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:central nervous system pharmacology
    n1=en:pharmacokinetic study | n2=en:central nervous system pharmacology | rel=r_associated | relid=0 | w=20
  31. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:centrifugation
    n1=en:pharmacokinetic study | n2=en:centrifugation | rel=r_associated | relid=0 | w=20
  32. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:chemistry test
    n1=en:pharmacokinetic study | n2=en:chemistry test | rel=r_associated | relid=0 | w=20
  33. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:clinical bioequivalence or bioavailability study
    n1=en:pharmacokinetic study | n2=en:clinical bioequivalence or bioavailability study | rel=r_associated | relid=0 | w=20
  34. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:cyclobenzaprine measurement
    n1=en:pharmacokinetic study | n2=en:cyclobenzaprine measurement | rel=r_associated | relid=0 | w=20
  35. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:cytologic test
    n1=en:pharmacokinetic study | n2=en:cytologic test | rel=r_associated | relid=0 | w=20
  36. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:cytological procedure
    n1=en:pharmacokinetic study | n2=en:cytological procedure | rel=r_associated | relid=0 | w=20
  37. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:dental pharmacology
    n1=en:pharmacokinetic study | n2=en:dental pharmacology | rel=r_associated | relid=0 | w=20
  38. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:dopamine measurement
    n1=en:pharmacokinetic study | n2=en:dopamine measurement | rel=r_associated | relid=0 | w=20
  39. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:dose
    n1=en:pharmacokinetic study | n2=en:dose | rel=r_associated | relid=0 | w=20
  40. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:drug distribution volume
    n1=en:pharmacokinetic study | n2=en:drug distribution volume | rel=r_associated | relid=0 | w=20
  41. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:drug resistance process
    n1=en:pharmacokinetic study | n2=en:drug resistance process | rel=r_associated | relid=0 | w=20
  42. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:electrophoresis
    n1=en:pharmacokinetic study | n2=en:electrophoresis | rel=r_associated | relid=0 | w=20
  43. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:électrophoretic
    n1=en:pharmacokinetic study | n2=en:électrophoretic | rel=r_associated | relid=0 | w=20
  44. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:elimination rate constant
    n1=en:pharmacokinetic study | n2=en:elimination rate constant | rel=r_associated | relid=0 | w=20
  45. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:excretion measurement
    n1=en:pharmacokinetic study | n2=en:excretion measurement | rel=r_associated | relid=0 | w=20
  46. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:fecal occult blood test
    n1=en:pharmacokinetic study | n2=en:fecal occult blood test | rel=r_associated | relid=0 | w=20
  47. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:felbamate measurement
    n1=en:pharmacokinetic study | n2=en:felbamate measurement | rel=r_associated | relid=0 | w=20
  48. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:fluorescent antibody procedure
    n1=en:pharmacokinetic study | n2=en:fluorescent antibody procedure | rel=r_associated | relid=0 | w=20
  49. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:griseofulvin measurement
    n1=en:pharmacokinetic study | n2=en:griseofulvin measurement | rel=r_associated | relid=0 | w=20
  50. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:hematologic tests
    n1=en:pharmacokinetic study | n2=en:hematologic tests | rel=r_associated | relid=0 | w=20
  51. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:hematology test
    n1=en:pharmacokinetic study | n2=en:hematology test | rel=r_associated | relid=0 | w=20
  52. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:histologic test
    n1=en:pharmacokinetic study | n2=en:histologic test | rel=r_associated | relid=0 | w=20
  53. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:immunologic technique
    n1=en:pharmacokinetic study | n2=en:immunologic technique | rel=r_associated | relid=0 | w=20
  54. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:immunology test
    n1=en:pharmacokinetic study | n2=en:immunology test | rel=r_associated | relid=0 | w=20
  55. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:laboratory calculation
    n1=en:pharmacokinetic study | n2=en:laboratory calculation | rel=r_associated | relid=0 | w=20
  56. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:laboratory infertility studies
    n1=en:pharmacokinetic study | n2=en:laboratory infertility studies | rel=r_associated | relid=0 | w=20
  57. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:levomeprazine measurement
    n1=en:pharmacokinetic study | n2=en:levomeprazine measurement | rel=r_associated | relid=0 | w=20
  58. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:microbiology test
    n1=en:pharmacokinetic study | n2=en:microbiology test | rel=r_associated | relid=0 | w=20
  59. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:normaprotiline measurement
    n1=en:pharmacokinetic study | n2=en:normaprotiline measurement | rel=r_associated | relid=0 | w=20
  60. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:organ or system related test
    n1=en:pharmacokinetic study | n2=en:organ or system related test | rel=r_associated | relid=0 | w=20
  61. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:pharmacokinetic parameter
    n1=en:pharmacokinetic study | n2=en:pharmacokinetic parameter | rel=r_associated | relid=0 | w=20
  62. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:pipradrol measurement
    n1=en:pharmacokinetic study | n2=en:pipradrol measurement | rel=r_associated | relid=0 | w=20
  63. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:prolintane measurement
    n1=en:pharmacokinetic study | n2=en:prolintane measurement | rel=r_associated | relid=0 | w=20
  64. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:radioimmunoassay
    n1=en:pharmacokinetic study | n2=en:radioimmunoassay | rel=r_associated | relid=0 | w=20
  65. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:radioligand assay
    n1=en:pharmacokinetic study | n2=en:radioligand assay | rel=r_associated | relid=0 | w=20
  66. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:stimulation, chemical
    n1=en:pharmacokinetic study | n2=en:stimulation, chemical | rel=r_associated | relid=0 | w=20
  67. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:suppression test
    n1=en:pharmacokinetic study | n2=en:suppression test | rel=r_associated | relid=0 | w=20
  68. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> en:thiopental measurement
    n1=en:pharmacokinetic study | n2=en:thiopental measurement | rel=r_associated | relid=0 | w=20
  69. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> épreuve de freinage
    n1=en:pharmacokinetic study | n2=épreuve de freinage | rel=r_associated | relid=0 | w=20
  70. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> radio-immunoessai
    n1=en:pharmacokinetic study | n2=radio-immunoessai | rel=r_associated | relid=0 | w=20
  71. en:pharmacokinetic study -- r_associated #0: 20 / 0.571 -> tests hématologiques
    n1=en:pharmacokinetic study | n2=tests hématologiques | rel=r_associated | relid=0 | w=20
≈ 82 relations entrantes

  1. tests hématologiques --- r_associated #0: 311 --> en:pharmacokinetic study
    n1=tests hématologiques | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=311
  2. en:hematologic tests --- r_associated #0: 310 --> en:pharmacokinetic study
    n1=en:hematologic tests | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=310
  3. electrophoresis --- r_associated #0: 100 --> en:pharmacokinetic study
    n1=electrophoresis | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=100
  4. en:electrophoresis --- r_associated #0: 98 --> en:pharmacokinetic study
    n1=en:electrophoresis | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=98
  5. électrophorèse --- r_associated #0: 80 --> en:pharmacokinetic study
    n1=électrophorèse | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=80
  6. en:fecal occult blood test --- r_associated #0: 56 --> en:pharmacokinetic study
    n1=en:fecal occult blood test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=56
  7. dépistage de sang occulte dans les selles --- r_associated #0: 55 --> en:pharmacokinetic study
    n1=dépistage de sang occulte dans les selles | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=55
  8. en:centrifugation --- r_associated #0: 55 --> en:pharmacokinetic study
    n1=en:centrifugation | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=55
  9. centrifugation --- r_associated #0: 54 --> en:pharmacokinetic study
    n1=centrifugation | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=54
  10. en:laboratory infertility studies --- r_associated #0: 41 --> en:pharmacokinetic study
    n1=en:laboratory infertility studies | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=41
  11. en:chemistry test --- r_associated #0: 40 --> en:pharmacokinetic study
    n1=en:chemistry test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=40
  12. en:dose --- r_associated #0: 40 --> en:pharmacokinetic study
    n1=en:dose | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=40
  13. en:radioligand assay --- r_associated #0: 39 --> en:pharmacokinetic study
    n1=en:radioligand assay | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=39
  14. dose --- r_associated #0: 38 --> en:pharmacokinetic study
    n1=dose | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=38
  15. constance de vitesse d'élimination --- r_associated #0: 37 --> en:pharmacokinetic study
    n1=constance de vitesse d'élimination | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=37
  16. en:clinical bioequivalence or bioavailability study --- r_associated #0: 37 --> en:pharmacokinetic study
    n1=en:clinical bioequivalence or bioavailability study | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=37
  17. en:laboratory test order cancelation --- r_associated #0: 37 --> en:pharmacokinetic study
    n1=en:laboratory test order cancelation | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=37
  18. en:elimination rate constant --- r_associated #0: 36 --> en:pharmacokinetic study
    n1=en:elimination rate constant | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=36
  19. dosage de l'acébutolol --- r_associated #0: 35 --> en:pharmacokinetic study
    n1=dosage de l'acébutolol | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=35
  20. en:acebutolol measurement --- r_associated #0: 35 --> en:pharmacokinetic study
    n1=en:acebutolol measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=35
  21. en:central nervous system pharmacology --- r_associated #0: 35 --> en:pharmacokinetic study
    n1=en:central nervous system pharmacology | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=35
  22. en:dimethadione measurement --- r_associated #0: 35 --> en:pharmacokinetic study
    n1=en:dimethadione measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=35
  23. en:drug resistance process --- r_associated #0: 35 --> en:pharmacokinetic study
    n1=en:drug resistance process | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=35
  24. en:normaprotiline measurement --- r_associated #0: 35 --> en:pharmacokinetic study
    n1=en:normaprotiline measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=35
  25. électrophorétique --- r_associated #0: 35 --> en:pharmacokinetic study
    n1=électrophorétique | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=35
  26. en:activation test --- r_associated #0: 34 --> en:pharmacokinetic study
    n1=en:activation test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=34
  27. en:dopamine measurement --- r_associated #0: 34 --> en:pharmacokinetic study
    n1=en:dopamine measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=34
  28. en:phenolsulfonphthalein measurement --- r_associated #0: 34 --> en:pharmacokinetic study
    n1=en:phenolsulfonphthalein measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=34
  29. en:breath test --- r_associated #0: 32 --> en:pharmacokinetic study
    n1=en:breath test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=32
  30. en:cytological procedure --- r_associated #0: 32 --> en:pharmacokinetic study
    n1=en:cytological procedure | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=32
  31. en:pipradrol measurement --- r_associated #0: 32 --> en:pharmacokinetic study
    n1=en:pipradrol measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=32
  32. étude pharmacocinétique --- r_associated #0: 32 --> en:pharmacokinetic study
    n1=étude pharmacocinétique | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=32
  33. dosage du thiopental --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=dosage du thiopental | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  34. en:acepromazine measurement --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:acepromazine measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  35. en:bioassay --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:bioassay | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  36. en:cyclobenzaprine measurement --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:cyclobenzaprine measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  37. en:excretion measurement --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:excretion measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  38. en:felbamate measurement --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:felbamate measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  39. en:immunologic technique --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:immunologic technique | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  40. en:organ or system related test --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:organ or system related test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  41. en:radioimmunoassay --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:radioimmunoassay | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  42. en:thiopental measurement --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=en:thiopental measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  43. radio-immunoessai --- r_associated #0: 31 --> en:pharmacokinetic study
    n1=radio-immunoessai | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=31
  44. effet indésirable d'un médicament --- r_associated #0: 30 --> en:pharmacokinetic study
    n1=effet indésirable d'un médicament | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=30
  45. en:adverse reaction to drug --- r_associated #0: 30 --> en:pharmacokinetic study
    n1=en:adverse reaction to drug | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=30
  46. en:cytologic test --- r_associated #0: 30 --> en:pharmacokinetic study
    n1=en:cytologic test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=30
  47. en:dental pharmacology --- r_associated #0: 30 --> en:pharmacokinetic study
    n1=en:dental pharmacology | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=30
  48. en:histologic test --- r_associated #0: 30 --> en:pharmacokinetic study
    n1=en:histologic test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=30
  49. en:laboratory calculation --- r_associated #0: 30 --> en:pharmacokinetic study
    n1=en:laboratory calculation | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=30
  50. en:suppression test --- r_associated #0: 30 --> en:pharmacokinetic study
    n1=en:suppression test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=30
  51. épreuve de freinage --- r_associated #0: 30 --> en:pharmacokinetic study
    n1=épreuve de freinage | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=30
  52. en:bioavailability study --- r_associated #0: 29 --> en:pharmacokinetic study
    n1=en:bioavailability study | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=29
  53. en:immunology test --- r_associated #0: 29 --> en:pharmacokinetic study
    n1=en:immunology test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=29
  54. en:nuclear magnetic resonance measurement --- r_associated #0: 29 --> en:pharmacokinetic study
    n1=en:nuclear magnetic resonance measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=29
  55. en:drug distribution volume --- r_associated #0: 28 --> en:pharmacokinetic study
    n1=en:drug distribution volume | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=28
  56. en:evaluation of acid-base balance --- r_associated #0: 28 --> en:pharmacokinetic study
    n1=en:evaluation of acid-base balance | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=28
  57. en:griseofulvin measurement --- r_associated #0: 28 --> en:pharmacokinetic study
    n1=en:griseofulvin measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=28
  58. en:area under curve --- r_associated #0: 27 --> en:pharmacokinetic study
    n1=en:area under curve | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=27
  59. en:fluorescent antibody procedure --- r_associated #0: 27 --> en:pharmacokinetic study
    n1=en:fluorescent antibody procedure | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=27
  60. en:levomeprazine measurement --- r_associated #0: 27 --> en:pharmacokinetic study
    n1=en:levomeprazine measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=27
  61. en:mephenytoin measurement --- r_associated #0: 27 --> en:pharmacokinetic study
    n1=en:mephenytoin measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=27
  62. en:microbiology test --- r_associated #0: 27 --> en:pharmacokinetic study
    n1=en:microbiology test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=27
  63. en:pharmacokinetic parameter --- r_associated #0: 27 --> en:pharmacokinetic study
    n1=en:pharmacokinetic parameter | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=27
  64. Électrophorèse --- r_associated #0: 27 --> en:pharmacokinetic study
    n1=Électrophorèse | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=27
  65. en:acetaminophen assay --- r_associated #0: 26 --> en:pharmacokinetic study
    n1=en:acetaminophen assay | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=26
  66. en:anti-d titration --- r_associated #0: 26 --> en:pharmacokinetic study
    n1=en:anti-d titration | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=26
  67. en:clinical evaluation --- r_associated #0: 26 --> en:pharmacokinetic study
    n1=en:clinical evaluation | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=26
  68. en:hematology test --- r_associated #0: 26 --> en:pharmacokinetic study
    n1=en:hematology test | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=26
  69. en:prolintane measurement --- r_associated #0: 26 --> en:pharmacokinetic study
    n1=en:prolintane measurement | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=26
  70. en:stimulation, chemical --- r_associated #0: 26 --> en:pharmacokinetic study
    n1=en:stimulation, chemical | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=26
  71. en:électrophoretic --- r_associated #0: 26 --> en:pharmacokinetic study
    n1=en:électrophoretic | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=26
  72. Centrifugation --- r_associated #0: 23 --> en:pharmacokinetic study
    n1=Centrifugation | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=23
  73. alcootest --- r_associated #0: 22 --> en:pharmacokinetic study
    n1=alcootest | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=22
  74. CPEF --- r_associated #0: 15 --> en:pharmacokinetic study
    n1=CPEF | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=15
  75. Electrophoresis --- r_associated #0: 15 --> en:pharmacokinetic study
    n1=Electrophoresis | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=15
  76. dosage radio-immunologique --- r_associated #0: 10 --> en:pharmacokinetic study
    n1=dosage radio-immunologique | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=10
  77. effet de souffle (lésion par) --- r_associated #0: 10 --> en:pharmacokinetic study
    n1=effet de souffle (lésion par) | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=10
  78. en:side effects of drug --- r_associated #0: 10 --> en:pharmacokinetic study
    n1=en:side effects of drug | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=10
  79. radiculocordonal postérieur (syndrome) --- r_associated #0: 10 --> en:pharmacokinetic study
    n1=radiculocordonal postérieur (syndrome) | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=10
  80. alcotest --- r_associated #0: 5 --> en:pharmacokinetic study
    n1=alcotest | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=5
  81. centreur lumineux --- r_associated #0: 5 --> en:pharmacokinetic study
    n1=centreur lumineux | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=5
  82. méthode radio-immunologique --- r_associated #0: 5 --> en:pharmacokinetic study
    n1=méthode radio-immunologique | n2=en:pharmacokinetic study | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr